Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market and Technology Background
Introduction
In vitro Diagnostics Technology
Overview
Classification of In Vitro Diagnostic Elements
Importance of In Vitro Diagnostics Technologies and Quality Control
Difference Between In Vitro and In Vivo Diagnostics
Regulations in the IVD Industry
Regulation of IVD Products in Different Countries

Chapter 3 Market Dynamics
Overview
Market Drivers
Rise in Population of Older Adults: Dependence on Diagnosis Procedures
Integration of Artificial Intelligence in Vitro Diagnostics
Rising Prevalence of Chronic Diseases
Improving the Quality of Point-of-Care Testing (POCT)
Market Restraints
Challenges Associated with Technologies Product Packaging
Increases in Shipping Costs or Service Issues
Laboratory Assistant’s Inability to Handle Laboratory Equipment and Consumables
Market Opportunities
Rise in Home Care Testing Devices
Demand for Point-of-Care (POC) Testing Units
Growing Demand for AI and the Internet of Things

Chapter 4 Emerging Technologies and Developments
Emerging Technologies in the IVD Market
Artificial Intelligence
Modified Old IVD Techniques
Liquid Biopsy
Automated In Vitro Diagnostic Devices
Emerging Developments in In Vitro Diagnostics
FDA Approval
Rise in Demand for Personalized Medicine
Lab Automation and Digital Health Platform
Portability Option in IVD Devices
Home Care Kits for Cancer Diagnosis
FDA Approved In Vitro Diagnostic Devices: AI Enabled

Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Technology
Immunochemistry
POC Testing
Hematology
Molecular Diagnostics
Tissue Diagnostics
Clinical Microbiology
Market Analysis by Application
Diabetes
Nephrology
Blood Glucose Evaluation and Monitoring (BGEM)
Oncology
Cardiology
Infectious Diseases
Other Applications
Market Analysis by End User
Diagnostic Laboratory
Hospitals and Clinics
Point-of-Care (POC) Centers
Other End Users
Geographical Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Chapter 6 Competitive Intelligence
Introduction
Global Analysis of Company Market Ranking
Glimpse of Leading In Vitro Diagnostics (IVD) Companies in China
Agreements, Collaborations and Partnerships
bioM?rieux Agreements
Siemens Healthineers and Sysmex Enter into a Global Agreement
Roche Enters into Agreement with Path AI
Quidel Corp. Signs Agreement to Acquire Ortho Clinical Diagnostics
In Vitro Diagnostics Companies and Start-Ups in 2021-2023
Diagopreutic Private Limited
Diatherax
IPLEXMED
Magnify Bioscience Inc.

Chapter 7 Sustainability in the In Vitro Diagnostics Industry: An ESG Perspective
Importance of ESG in In Vitro Diagnostics Manufacturing Industry
ESG Practices in the In Vitro Diagnostics Industry
Environmental Performance
Social Performance
Governance Performance
Company Role in ESG Development
ESG Risk Ratings

Chapter 8 Appendix
Research Methodology
References
Company Profiles
ABBOTT
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
F. HOFFMANN-LA ROCHE LTD.
HOLOGIC INC.
JSR CORP.
QUIDELORTHO CORP.
SIEMENS HEATHNIEERS AG
SYSMEX CORP.
THERMO FISHER SCIENTIFIC INC.



List of Figures


Summary Figure : Global Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 1 : Snapshot of Market Dynamics
Figure 2 : Older Adults Using Technology to Manage Chronic Health Issues in the U.S., by Age Group, 2024
Figure 3 : Percentage of People Aged 50+ Using Digital Services in the U.S., 2024
Figure 4 : Breakdown of Global Elderly Population (Aged 65+ Years), by Select Countries, 2022
Figure 5 : Emerging AI Applications in In Vitro Diagnostics
Figure 6 : Global Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 7 : Global Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 8 : Snapshot of IVD Tests in Oncology
Figure 9 : Global Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 10 : Global Market Shares of In Vitro Diagnostics, by Region, 2023
Figure 11 : North American Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 12 : North American Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 13 : North American Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 14 : North American Market Shares of In Vitro Diagnostics, by Country, 2023
Figure 15 : European Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 16 : European Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 17 : European Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 18 : European Market Shares of In Vitro Diagnostics, by Sub-Region , 2023
Figure 19 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 20 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 21 : Asia-Pacific Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 22 : Asia-Pacific Market Shares of In Vitro Diagnostics, by Country, 2023
Figure 23 : Latin American Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 24 : Latin American Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 25 : Latin American Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 26 : Latin American Market Shares of In Vitro Diagnostics, by Sub-Region, 2023
Figure 27 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Technology, 2023
Figure 28 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Application, 2023
Figure 29 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by End User, 2023
Figure 30 : Middle Eastern and African Market Shares of In Vitro Diagnostics, by Sub-Region, 2023
Figure 31 : Rankings of Leading Companies in Global In Vitro Diagnostics Market, 2023
Figure 32 : Snapshot: Key ESG Trends in the In Vitro Diagnostics Industry
Figure 33 : Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 34 : Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 35 : BD: Revenue Shares, by Business Unit, FY 2023
Figure 36 : BD: Revenue Shares, by Country/Region, FY 2023
Figure 37 : BIOM?RIEUX: Revenue Shares, by Business Unit, FY 2023
Figure 38 : BIOM?RIEUX: Revenue Shares, by Country/Region, FY 2023
Figure 39 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 40 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 41 : Bio-Techne: Revenue Shares, by Business Unit, FY 2023
Figure 42 : Bio-Techne: Revenue Shares, by Country/Region, FY 2023
Figure 43 : Bruker: Revenue Shares, by Business Unit, FY 2023
Figure 44 : Bruker: Revenue Shares, by Country/Region, FY 2023
Figure 45 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 46 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 47 : EKF Diagnostics Holdings plc.: Revenue Shares, by Business Unit, FY 2023
Figure 48 : EKF Diagnostics Holdings plc.: Revenue Shares, by Country/Region, FY 2023
Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 50 : F. Hoffmann-La Roche Ltd.: Revenue Shares, by Country/Region, FY 2023
Figure 51 : Hologic Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 52 : Hologic Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 53 : JSR Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 54 : JSR Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 55 : QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 56 : QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 57 : Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2023
Figure 58 : Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2023
Figure 59 : Sysmex Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 60 : Sysmex Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 61 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 62 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023

List of Tables


Summary Table : Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 1 : Approved FDA In Vitro Diagnostics Devices, 2021–2024
Table 2 : Differences Between In Vitro and In Vivo Diagnostics
Table 3 : FDA Approval of Artificial Intelligence and Machine Learning–Enabled Medical Devices, 2024
Table 4 : Global Market for In Vitro Diagnostics, by Technology, Through 2029
Table 5 : Global Market for In Vitro Diagnostics in Immunochemistry, by Region, Through 2029
Table 6 : Global Market for In Vitro Diagnostics in POC Testing, by Region, Through 2029
Table 7 : Summary of Electrochemiluminescence POCT Devices with Their Analytic Performance
Table 8 : Global Market for In Vitro Diagnostics in Hematology, by Region, Through 2029
Table 9 : Global Market for In Vitro Diagnostics in Molecular Diagnostics, by Region, Through 2029
Table 10 : Global Market for In Vitro Diagnostics in Tissue Diagnostics, by Region, Through 2029
Table 11 : Global Market for In Vitro Diagnostics in Clinical Microbiology, by Region, Through 2029
Table 12 : Global Market for In Vitro Diagnostics, by Application, Through 2029
Table 13 : Global Market for Diabetes in In Vitro Diagnostics, by Region, Through 2029
Table 14 : Global Market for Nephrology in In Vitro Diagnostics, by Region, Through 2029
Table 15 : Global Market for BGEM in In Vitro Diagnostics, by Region, Through 2029
Table 16 : Global Market for Oncology in In Vitro Diagnostics, by Region, Through 2029
Table 17 : Global Market for Cardiology in In Vitro Diagnostics, by Region, Through 2029
Table 18 : Global Market for Infectious Diseases in In Vitro Diagnostics, by Region, Through 2029
Table 19 : Global Market for Other Applications in In Vitro Diagnostics, by Region, Through 2029
Table 20 : Global Market for In Vitro Diagnostics, by End User, Through 2029
Table 21 : Global Market for In Vitro Diagnostics for Diagnostic Laboratory, by Region, Through 2029
Table 22 : Global Market for In Vitro Diagnostics for Hospitals and Clinics, by Region, Through 2029
Table 23 : Global Market for In Vitro Diagnostics for Point-of-Care Centers, by Region, Through 2029
Table 24 : Global Market for In Vitro Diagnostics for Other End Users, by Region, Through 2029
Table 25 : Global Market for In Vitro Diagnostics, by Region, Through 2029
Table 26 : North American Market for In Vitro Diagnostics, by Country, Through 2029
Table 27 : European Market for In Vitro Diagnostics, by Country, Through 2029
Table 28 : Asia-Pacific Market for In Vitro Diagnostics, by Country, Through 2029
Table 29 : Latin American Market for In Vitro Diagnostics, by Sub-Region, Through 2029
Table 30 : Total Imports of Medical Equipment into Brazil, 2021 and 2022
Table 31 : Middle Eastern and African Market for In Vitro Diagnostics Technology, by Sub-Region, Through 2029
Table 32 : bioM?rieux Agreements
Table 33 : ESG Practices: Environmental Performance
Table 34 : ESG Practices: Social Performance
Table 35 : ESG Practices: Governance Performance
Table 36 : Creating an Attractive Workplace: Social Performance
Table 37 : ESG Rankings for Leading In Vitro Diagnostics Companies, 2023 and 2024*
Table 38 : Abbott: Company Snapshot
Table 39 : Abbott: Financial Performance, FY 2022 and 2023
Table 40 : Abbott: Product Portfolio
Table 41 : Abbott: News/Key Developments, 2022-2024
Table 42 : BD: Company Snapshot
Table 43 : BD: Financial Performance, FY 2022 and 2023
Table 44 : BD: Product Portfolio
Table 45 : BD: News/Key Developments, 2022-2024
Table 46 : BIOM?RIEUX: Company Snapshot
Table 47 : BIOM?RIEUX: Financial Performance, FY 2022 and 2023
Table 48 : BIOM?RIEUX: Product Portfolio
Table 49 : BIOM?RIEUX: News/Key Developments, 2023 and 2024
Table 50 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 51 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 52 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 53 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 54 : Bio-Techne: Company Snapshot
Table 55 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 56 : Bio-Techne: Product Portfolio
Table 57 : Bio-Techne: News/Key Developments, 2022 and 2023
Table 58 : Bruker: Company Snapshot
Table 59 : Bruker: Financial Performance, FY 2022 and 2023
Table 60 : Bruker: Product Portfolio
Table 61 : Bruker: News/Key Developments, 2021-2024
Table 62 : Danaher Corp.: Company Snapshot
Table 63 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 64 : Danaher Corp.: Product Portfolio
Table 65 : Danaher Corp.: News/Key Developments, 2021-2023
Table 66 : EKF Diagnostics Holdings plc.: Company Snapshot
Table 67 : EKF Diagnostics Holdings plc.: Financial Performance, FY 2022 and 2023
Table 68 : EKF Diagnostics Holdings plc.: Product Portfolio
Table 69 : EKF Diagnostics Holdings plc.: News/Key Developments, 2022-2024
Table 70 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 71 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 72 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 73 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
Table 74 : Hologic Inc.: Company Snapshot
Table 75 : Hologic Inc.: Financial Performance, FY 2022 and 2023
Table 76 : Hologic Inc.: Product Portfolio
Table 77 : Hologic Inc.: News/Key Developments, 2022-2024
Table 78 : JSR Corp.: Company Snapshot
Table 79 : JSR Corp.: Financial Performance, FY 2022 and 2023
Table 80 : JSR Corp.: Product Portfolio
Table 81 : JSR Corp.: News/Key Developments, 2024
Table 82 : QuidelOrtho Corp.: Company Snapshot
Table 83 : QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023
Table 84 : QuidelOrtho Corp.: Product Portfolio
Table 85 : QuidelOrtho Corp.: News/Key Developments, 2021-2024
Table 86 : Siemens Healthineers AG: Company Snapshot
Table 87 : Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 88 : Siemens Healthineers AG: Product Portfolio
Table 89 : Siemens Healthineers AG: News/Key Developments, 2021-2024
Table 90 : Sysmex Corp.: Company Snapshot
Table 91 : Sysmex Corp.: Financial Performance, FY 2022 and 2023
Table 92 : Sysmex Corp.: Product Portfolio
Table 93 : Sysmex Corp.: News/Key Developments, 2022 and 2023
Table 94 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 95 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 96 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 97 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023